European Journal of Cancer
Volume 46, Issue 1 , Pages 72-83 , January 2010

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

Presented in part at the 44th Annual Meeting of the American Society of Clinical Oncology, May 30–June 3, 2008, Chicago, Illinois.

  • Stefan Sleijfer

      Affiliations

    • Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Address: Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. Tel.: +31 (0)10 7041733; fax: +31 (0)10 7041003.
    • ,
  • Monia Ouali

      Affiliations

    • EORTC Data Center, Brussels, Belgium
    • ,
  • Martine van Glabbeke

      Affiliations

    • EORTC Data Center, Brussels, Belgium
    • ,
  • Anders Krarup-Hansen

      Affiliations

    • Department of Oncology, University Hospital Herlev, Copenhagen, Denmark
    • ,
  • Sjoerd Rodenhuis

      Affiliations

    • Department of Medical Oncology, National Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Axel Le Cesne

      Affiliations

    • Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France
    • ,
  • Pancras C.W. Hogendoorn

      Affiliations

    • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Jaap Verweij

      Affiliations

    • Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Jean-Yves Blay

      Affiliations

    • Department of Medical Oncology, Centre Leon Berard, Lyon, France

Received 29 July 2009 ,Revised 13 September 2009 ,Accepted 17 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00719-9

doi: 10.1016/j.ejca.2009.09.022

European Journal of Cancer
Volume 46, Issue 1 , Pages 72-83 , January 2010

Article Tools

* Image Usage & Resolution